BBOTVSLABT• 7 Days (Normalized)
BBOT vs LABT (BridgeBio Oncology Therapeutics Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 25 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-1.52%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
LABT Performance $0.93
-44.16%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+42.64 pts
BBOT outperforming by 42.64 percentage points
BBOTLABT
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BBOT Price | BBOT Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -1.52% | $0.93 | -44.16% | +42.64% |
| Sep 30, 2026 | $4.10 | +3.80% | $- | - | |
| Sep 29, 2026 | $3.92 | -0.76% | $0.99 | -40.72% | +39.96% |
| Sep 28, 2026 | $3.81 | -3.54% | $1.15 | -31.14% | +27.60% |
| Sep 25, 2026 | $3.95 | +0.00% | $1.67 | +0.00% | +0.00% |